ESLA Award Disclosure
Pussinen Cynthia · SEC Form 4 · Filed Nov 4, 2026
Award
Calculated transaction value
$0
Pussinen Cynthia Chief Executive Officer
ESLA
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
ESLA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 1,000,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002163153-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Estrella Immunopharma, Inc. ESLA Current | Award | Nov 2, 2026 | $0 |